Dimensional Fund Advisors LP Catalyst Pharmaceuticals, Inc. Transaction History
Dimensional Fund Advisors LP
- $363 Billion
- Q1 2024
A detailed history of Dimensional Fund Advisors LP transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,737,657 shares of CPRX stock, worth $42.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,737,657
Previous 2,601,797
5.22%
Holding current value
$42.4 Million
Previous $43.7 Million
0.22%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding CPRX
# of Institutions
277Shares Held
95.7MCall Options Held
40.6KPut Options Held
67.2K-
Black Rock Inc. New York, NY17.7MShares$275 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$141 Million3.01% of portfolio
-
State Street Corp Boston, MA8.15MShares$126 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.98MShares$124 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.73MShares$42.2 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $1.59B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...